SiriusPoint Ltd.

SiriusPoint Ltd. (SPNT) Market Cap

SiriusPoint Ltd. has a market capitalization of $2.55B.

Price: $21.72

0.69 (3.28%)

Market Cap: 2.55B

NYSE · time unavailable

CEO: Scott Egan

Sector: Financial Services

Industry: Insurance - Reinsurance

IPO Date: 2013-08-15

Website: https://www.siriuspt.com

SiriusPoint Ltd. (SPNT) - Company Information

Market Cap: 2.55B|Sector: Financial Services

Company Profile

SiriusPoint Ltd. provides multi-line insurance and reinsurance products and services worldwide. The company operates through two segments, Reinsurance, and Insurance & Services. The Reinsurance segment provides coverage to various product lines, which includes aviation and space, casualty, contingency, credit and bond, marine and energy, mortgage, and property to insurance and reinsurance companies, government entities, and other risk bearing vehicles. The Insurance & Services segment offers coverage to various product lines comprising accident and health, environmental, workers' compensation, and other lines of business, including a cross section of property and casualty lines. The company was formerly known as Third Point Reinsurance Ltd. and changed its name to SiriusPoint Ltd. in February 2021. SiriusPoint Ltd. was incorporated in 2011 and is headquartered in Pembroke, Bermuda.

Analyst Sentiment

67%
Buy

From 4 Active Polls

1Y Forecast: $25.00

▲ +15.1% Potential Upside

Consensus Target Metrics

Low Bound

$25

Median

$25

High Bound

$25

Average

$25

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$25.00
▲ +15.10% Upside
Low Target
$25.00
15% Risk
Median Target
$25.00
15% Mid
High Target
$25.00
15% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)2,5532,5162,5572,1123,2902,7902,6452,3762,071
Enterprise Value ($M)2,2452,2082,5142,2123,2362,7132,6022,3952,122
Price to Earnings Ratio (P/E)5.076.152.625.8113.0211.32-38.2269.874.55
Price/Earnings-to-Growth Ratio (PEG)0.091.9345.210.68-3.210.62
Price to Sales Ratio (P/S)0.793.252.632.804.503.834.234.252.80
Price to Book Ratio (P/B)1.101.091.040.961.561.381.370.880.77
Price to Free Cash Flow Ratio (P/FCF)7.8117.75-90.9813.6156.54-31.3924.5640.89-13.60
Enterprise Value to Sales (EV/Sales)2.852.582.944.423.724.164.282.87
Enterprise Value to EBITDA (EV/EBITDA)3.3315.678.3916.4232.7628.18260.2185.8514.36
Debt to Equity Ratio-0.460.310.280.310.320.330.330.250.24

SPNT Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$21.72
Intrinsic Value$148.54
Market Alignment
Undervalued by 583.9%relative to calculated intrinsic value
9.00%
Exp: 10%10%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$1.33B
Perpetuity TV Value$24.95B
Discounted TV (PV)$10.54B
TV Weighting %61.6%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 SIRIUSPOINT LTD (SPNT) — Investment Overview

🧩 Business Model Overview

SiriusPoint is a specialty insurer and reinsurer that earns premiums by underwriting insurance risks and then transferring selected exposures across the reinsurance stack. The business converts underwriting discipline into distributable value by balancing: (1) premium volume and pricing, (2) risk selection (class/territory/coverage-level underwriting), (3) exposure management (aggregate risk controls and catastrophe modeling), and (4) investment returns on held capital.

A core feature of the model is that the economics are determined less by “sales execution” and more by underwriting cycle positioning and reserving accuracy. Business performance depends on maintaining profitability over full loss-development horizons and retaining sufficient capital to write risks through market turns.

💰 Revenue Streams & Monetisation Model

Revenue is driven primarily by gross and net premiums from insurance and reinsurance contracts. Net income is then influenced by:

  • Underwriting spread: earned premiums minus incurred claims and expenses (a function of pricing adequacy and loss/expense management).
  • Investment income on underwriting capital: investment portfolio returns that offset part of the underwriting result and support book value stability.
  • Timing effects from reserves: future loss payments are estimated through reserves; favorable or adverse development can materially affect earnings through the loss tail.

Margin drivers typically center on maintaining underwriting profitability (discipline on rate adequacy and terms), controlling catastrophe and large-loss exposure, and preserving operating leverage in expenses.

🧠 Competitive Advantages & Market Positioning

SiriusPoint’s moat is primarily rooted in risk selection capability, capital and underwriting discipline, and relationships/access to business. In specialty insurance/reinsurance, competitors cannot easily replicate a consistently profitable underwriting “engine because it is earned over time through datasets, modeling, claims analytics, and loss-experience feedback loops.

  • Underwriting & reserving track record (intangible asset): Consistent performance depends on loss analytics, underwriting governance, and disciplined reserve setting. This competence compounds, making market share difficult to gain without credibility in the book.
  • Capital efficiency and balance-sheet resilience: Writing risk profitably requires maintaining capacity through stress periods. Strong capital positioning supports continuity of underwriting and participation when terms improve.
  • Broker/cedant relationships: Specialty placements often rely on trust, service quality, and reliability during claim events. This reduces practical “switching” for counterparties.

Competitive benchmarking:

  • Arch Capital Group and RenaissanceRe are prominent peers in specialty insurance/reinsurance, competing for risk selection, pricing, and portfolio fit with strong underwriting teams.
  • Hiscox is another key competitor in specialty lines and reinsurance, with focus areas that can overlap depending on class and region.

Compared with these rivals, SiriusPoint’s competitive positioning emphasizes breadth in specialty underwriting and the ability to manage aggregate risk while participating across the insurance/reinsurance market where pricing and risk appetite are favorable—rather than relying on a single line of business.

🚀 Multi-Year Growth Drivers

The strongest multi-year drivers for SiriusPoint align with structural characteristics of insurance markets and capital dynamics:

  • Underwriting cycle support: Specialty insurance economics tend to benefit when pricing lags loss inflation and capital becomes constrained. Profitable underwriting during “firming” periods can be a platform for multi-year book value growth.
  • Increasing complexity of insured risks: Growth in cyber exposure, evolving liability regimes, and specialty coverage needs can expand demand for specialist risk transfer—often favoring firms with sophisticated underwriting.
  • Catastrophe and climate volatility: Higher frequency/severity uncertainty tends to increase demand for reinsurance and risk-spread structures, supporting the role of capital markets in transferring risk.
  • Alternative capital penetration: Over a cycle, reinsurers with disciplined underwriting can access improved terms as new capital reallocates toward specialty segments where underwriting skill is valued.

⚠ Risk Factors to Monitor

  • Catastrophe and large-loss volatility: Weather-related events and other tail risks can cause outsized claims and impair underwriting results.
  • Reserve and model risk: Loss reserving uncertainty and catastrophe model assumptions can lead to adverse development, affecting earnings and book value.
  • Pricing adequacy risk during competitive “softening”: Sustained premium growth without disciplined underwriting can compress margins over subsequent loss periods.
  • Regulatory/capital constraints: Changes in insurance regulation, capital requirements, or rating-agency criteria can influence capacity and cost of capital.
  • Investment risk: Portfolio duration, credit quality, and liquidity management affect investment income and capital stability, particularly in stress markets.

📊 Valuation & Market View

Markets for specialty insurers/reinsurers often value firms based on durable book value growth and earnings quality rather than purely on near-term income. Common valuation frameworks include:

  • Price-to-book / tangible book value: Reflects balance-sheet strength and the expectation of sustainable underwriting returns.
  • Return on equity and underwriting profitability measures: Evaluate how effectively the firm turns capital into profit.
  • Combined-ratio logic (for insurers) and loss ratio/expense ratio mix: Assesses underwriting discipline and operating leverage.
  • Investment yield sensitivity: Portfolio credit quality and duration shape earnings resilience.

Key variables that typically move valuation include demonstrated underwriting consistency, resilience through catastrophe stress, and credible reserve development patterns that support compounding of tangible capital.

🔍 Investment Takeaway

SiriusPoint’s long-term investment case rests on underwriting-driven compounding: a specialty insurance/reinsurance platform where the central “moat” is the ability to select risks well, price them adequately, and set reserves with discipline—backed by capital strength and established market relationships. For investors, the focus should remain on underwriting quality, reserve credibility, aggregate risk management, and balance-sheet resilience through loss volatility, as these factors determine whether the firm can translate market conditions into durable book value growth.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for SPNT.

globenewswire.com2026-05-26

SiriusPoint Strengthens London Market Specialty Division with Launch of Crisis Solutions Platform and Senior Appointments

HAMILTON, Bermuda, May 26, 2026 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (NYSE: SPNT) (“SiriusPoint” or “the Company”), a global specialty underwriter, today announced the launch of a new Crisis Solutions class of business within its London Market Specialty division. Paul Beattie and Ed Winter have been appointed as joint Heads of Crisis Solutions to lead the new offering.

seekingalpha.com2026-05-20

SiriusPoint Ltd. (SPNT) Shareholder/Analyst Call Prepared Remarks Transcript

SiriusPoint Ltd. (SPNT) Shareholder/Analyst Call Prepared Remarks Transcript

marketbeat.com2026-05-15

SiriusPoint Q1 Earnings Call Highlights

SiriusPoint NYSE: SPNT reported a strong start to 2026, with management pointing to improved underwriting profitability, lower catastrophe volatility and continued capital returns during the company's first-quarter earnings call.

seekingalpha.com2026-05-08

SiriusPoint Ltd. (SPNT) Q1 2026 Earnings Call Transcript

SiriusPoint Ltd. (SPNT) Q1 2026 Earnings Call Transcript

zacks.com2026-05-07

SiriusPoint (SPNT) Q1 Earnings Beat Estimates

SiriusPoint (SPNT) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.49 per share a year ago.

globenewswire.com2026-05-07

SiriusPoint Reports First Quarter 2026 Net Income of $100m, Return on Equity of 17.4% and Operating Return on Equity of 15.3%

HAMILTON, Bermuda, May 07, 2026 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE:SPNT), a specialty underwriter, today announced results for its first quarter ended March 31, 2026.

zacks.com2026-04-30

SiriusPoint (SPNT) Earnings Expected to Grow: Should You Buy?

SiriusPoint (SPNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com2026-04-29

Should Value Investors Buy SiriusPoint (SPNT) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

zacks.com2026-04-28

SiriusPoint Ltd. (SPNT) Hits Fresh High: Is There Still Room to Run?

SiriusPoint (SPNT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

defenseworld.net2026-04-24

Analysts Set SiriusPoint Ltd. (NYSE:SPNT) PT at $28.00

SiriusPoint Ltd. (NYSE: SPNT - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the six analysts that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, three have assigned a buy recommendation and one has given a strong buy recommendation to the

globenewswire.com2026-04-23

SiriusPoint Announces Date for First Quarter 2026 Earnings Release

HAMILTON, Bermuda, April 23, 2026 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (NYSE: SPNT) (“SiriusPoint” or the “Company”) today announced that it is planning to release its first quarter 2026 financial results after the market close on Thursday, May 7, 2026.

zacks.com2026-04-23

4 Multiline Insurers to Buy Amid Inflation, Low Interest Rate

Better pricing, product redesigns and technological advancements are expected to aid Zacks Multiline Insurance industry players like ACT, CNO, SPNT and SLDE.

globenewswire.com2026-04-21

S&P upgrades SiriusPoint's Insurance Subsidiaries to ‘A' based on consistent robust earnings and strength of capital position

HAMILTON, Bermuda, April 21, 2026 (GLOBE NEWSWIRE) -- S&P Global Ratings (“S&P”) has raised the long-term issuer credit and financial strength ratings on the core insurance operating subsidiaries of SiriusPoint Ltd (“SiriusPoint” or “the Company”) to 'A' from 'A-', marking the Company's third ratings upgrade this year. S&P has also raised its long-term issuer credit rating on the holding company, SiriusPoint Ltd., to 'BBB+' from 'BBB'. The outlook of these ratings is stable.

businesswire.com2026-04-16

AM Best Upgrades Credit Ratings of SiriusPoint Ltd. and Its Subsidiaries

LONDON--(BUSINESS WIRE)-- #insurance--AM Best has upgraded the Financial Strength Rating to A (Excellent) from A- (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) to “a” (Excellent) from “a-” (Excellent) of the rated operating subsidiaries of SiriusPoint Ltd. (SiriusPoint) (Bermuda) [NYSE: SPNT]. Additionally, AM Best has upgraded the Long-Term ICR to “bbb” (Good) from “bbb-” (Good) of SiriusPoint, which is a non-operating holding company. (See below for a detailed listing of the companie.

zacks.com2026-04-13

Are Investors Undervaluing SiriusPoint (SPNT) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"SPNT reported Q1 2026 revenue of $774.6M and net income of $102.2M (EPS $0.76). On a YoY basis (vs Q1 2025), revenue rose +6.2% ($729.4M to $774.6M) and net income increased +65.7% ($61.6M to $102.2M). On a QoQ basis (vs Q4 2025), revenue declined -20.4% ($973.7M to $774.6M), while net income fell -58.1% ($244.0M to $102.2M). Profitability improved meaningfully over the last year but was pressured sequentially. Gross margin expanded to 53.2% in Q1 2026 from 27.1% in Q1 2025, and net margin improved to 13.2% from 8.4% YoY. However, sequentially net margin contracted sharply (25.1% in Q4 2025 to 13.2% in Q1 2026), indicating mix and/or expense pressure. Interest coverage remains strong (7.2x). Cash generation was solid in Q1 2026 with operating cash flow of $141.7M and free cash flow of $141.7M. The company also returned capital via buybacks ($221.9M repurchased) with only $3.9M in dividends paid, supporting shareholder yield while maintaining balance-sheet resilience (net cash position, net debt -$307.8M; equity ~$2.30B). Total shareholder returns look favorable: the stock is up 42.3% over 1 year, which should materially enhance the overall rating versus valuation targets (consensus target $25 vs current $23.28)."

Revenue Growth

Neutral

Revenue +6.2% YoY in Q1 2026 ($774.6M vs $729.4M) but -20.4% QoQ ($774.6M vs $973.7M), suggesting volatility rather than smooth momentum.

Profitability

Strong

Net income +65.7% YoY and net margin improved to 13.2% (from 8.4% in Q1 2025). Sequentially profitability compressed (net margin 25.1% in Q4 to 13.2% in Q1).

Cash Flow Quality

Good

Operating cash flow of $141.7M in Q1 2026 with free cash flow also $141.7M. Capital returns via $221.9M buybacks and modest dividends ($3.9M) appear supported by earnings/cash generation.

Leverage & Balance Sheet

Positive

Net cash position improved (net debt -$307.8M vs -$42.6M in Q4 2025). Equity remains stable around ~$2.30B, indicating resilience despite sequential earnings decline.

Shareholder Returns

Strong

Strong price momentum: +42.3% 1-year change. Buybacks in Q1 2026 ($221.9M) further support total shareholder return; dividend yield remains small (~0.16%).

Analyst Sentiment & Valuation

Positive

Consensus price target $25 vs current $23.28 implies upside, but valuation multiples (e.g., P/E ~6.2) reflect improving profitability rather than a deep value setup.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

So what: SPNT delivered a high-quality Q1 with underwriting discipline and portfolio volatility reduction. The core combined ratio improved 6.5 points to 88.9% and underwriting income rose 149% to $71M, supported by materially lower catastrophe losses. While top-line is mixed—Insurance & Services grew 8% and Reinsurance shrank 10%—the company emphasized that adjusted growth was ~4% YoY and that full-year gross written premium guidance remains 5%–10% with Insurance weighted and double-digit Insurance growth targeted. Margin and fee metrics also strengthened: net fee income rose 34% and margins improved by 80 bps, with service revenue at a 14.6% margin. Capital returns accelerated: $200M preference redemption, $40M+ common buyback, and an additional $74M authorization increase. Risks are concentrated in competitive dynamics (GL terms softening) and property cat pricing decline (~15%), but management’s shift toward lower-volatility specialty and strict return thresholds is the core narrative.

AI IconGrowth Catalysts

  • Insurance & Services gross written premiums grew 8% YoY, led by Accident & Health (+9%) with travel and U.S. medical opportunities
  • Accident & Health described as low capital intensity/low correlation, improving portfolio resilience
  • Guidance for full-year gross written premium growth of 5% to 10%, with Insurance more weighted and double-digit Insurance growth targeted
  • Selective General Liability growth approach via MGA access to niche markets with strict price-to-risk discipline

Business Development

  • 2 new MGA relationships added in Q1 (for Insurance growth momentum)
  • Named achievement: won U.S. Program Carrier of the Year (referenced as last year)
  • Arcadian sale completion (referenced as impacting GAAP ROE and book value uplift)

AI IconFinancial Highlights

  • Core combined ratio 88.9% (lowest in 6 quarters); improved 6.5 points YoY
  • Underwriting income $71 million, up 149% YoY; 14th consecutive quarter of underwriting profitability
  • Operating net income $86 million or $0.70 diluted EPS, up 37% YoY
  • Operating ROE 15.3%; core operating ROE 17.9% (within and above 12%–15% through-the-cycle target range)
  • Insurance & Services gross written premium +8% YoY; Reinsurance gross written premium -10% (discipline in property cat)
  • Gross written premium $1.0B, +1% YoY; net written premium -7% (aggregate covers + prior-year onetime Surety item)
  • Adjusting for one-offs, gross and net written premiums grew ~4% YoY
  • Reinsurance combined ratio 84.2%, improved by ~13 points driven by lower catastrophe losses; partially offset by lower PYD and higher acquisition costs/expenses
  • Insurance & Services combined ratio 92%; ex-cat combined ratio improved by just over 0.5 point
  • Prior-year development favorable: $32 million within core and $18 million consolidated; 20 consecutive quarters of favorable development
  • Net service fee income $8 million; service revenues $54 million at 14.6% margin; net service revenues rose 26% excluding Arcadian sale
  • Net fee income +34%; margins improved by 80 basis points
  • Investment result $78 million; net investment income $66 million; no defaults; fixed income average credit quality AA-; reinvestment yields >4.5%; duration ~3.1 years
  • BSCR ratio 242% (first quarter); liquidity over $1 billion; leverage 23% (historic low)
  • Book value per diluted share (ex AOCI) increased 5% sequentially to $18.98

AI IconCapital Funding

  • Redeemed $200 million of preference shares
  • Bought back over $40 million of common shares as of early in the week
  • Increased buyback intention: $100 million commitment raised by remainder of existing authorization, adding $74 million (total buyback intention referenced to full pre-authorization amount of $174 million)
  • Debt to capital 22.8% (lowest level in several years)
  • Capital returned YTD/so far in 2026: over $240 million (preference share redemption + common buyback referenced)

AI IconStrategy & Ops

  • Portfolio reshaping continued: reduced catastrophe volatility; catastrophe losses $63 million lower YoY and represented 0.8 points on combined ratio vs 10.9 points in prior-year Q1
  • MGA partnership structure: no volume incentives; ~90% of partners linked to underwriting profits; reserves above pricing for new partners; profit commission accruals largely non-cash
  • Accident & Health growth: emphasized low correlation/resilience; employer stop-loss premiums generally flat since 2021; market showing early hardening
  • Reinsurance pricing discipline: property cat rate declines ~15%; gross written premium -31% reflecting lower reinstatement premiums and deliberate pullback
  • New disclosure: introduced a core business ROE metric focused on go-forward portfolio (excluding historically exited business; runoff sits outside core metrics)
  • Runoff discipline: no new additions since end of 2023; net runoff reserves under $500 million (down from just over $1 billion at end of 2023); portfolio expected ~90% reported by mid-2027
  • Lloyd’s/London market relaunch: relabeled London Market specialty with increased profile after prior remediation

AI IconMarket Outlook

  • Full-year gross written premium growth expected between 5% and 10%, with Insurance & Services weighted and shift from Reinsurance mix
  • Double-digit Insurance growth targeted for the year
  • Guidance reaffirmed: expense/other underwriting expense guidance range reiterated at 6.5% to 7% (management referred to reaffirming the full-year guidance range after noting elevated other underwriting expenses from timing items)
  • Reinsurance seasonality: gross/net premiums expected to be more even weight through the year due to reduced catastrophe concentration (property cat) and mix shift

AI IconRisks & Headwinds

  • P&C softness: management cited softening in parts of the market and emphasized discipline rather than broad growth
  • General Liability: competition intensifying as E&S market expands; selective term & conditions softening observed; excess casualty continues to price ahead of loss cost trends but underwriting remains cautious with strict return thresholds
  • Property Cat: rate declines about 15% and gross written premium down 31% with deliberate pullback; reinstatement premiums lower
  • Acquisition cost/expense volatility driven by profit commission accrual timing and prior-year development (modeled partner-by-partner sophistication; not extrapolatable directly)
  • Runoff: management noted continued losses in runoff but no notable incremental commentary; net runoff reserves still material (under $500 million)
  • Regime/geo risk: minimal claims from Middle East conflict referenced; management stated no significant impact on loss reserves from Baltimore Bridge Collapse estimate change

Q&A: Analyst Interest

  • General Liability growth despite intensifying competition: Management stressed they are alert in GL, seeing E&S-driven intensifying competition and selective T&C softening, but growth is approached via niche MGA access. They emphasized price-to-risk matching and moving capital away if returns don’t meet thresholds.
  • Insurance acquisition cost and profit commission modeling: Management said higher acquisition costs reflect MGA profit commission accruals tied to prior-year profits plus prior-year development; it’s accrual (not cash) and depends on partner-specific loss histories. They rejected simple extrapolation from Q1 PYD/acquisition lines.
  • London Market specialty relaunch impact timing: Management framed the move as a strategic journey, not newly created underwriting. They cited Lloyd’s syndicate remediation improving from fourth quartile to second quartile over ~3 years. A London event with Lloyd’s CEO Patrick Tiernan reinforced commitment; impacts to disclose if/when momentum snowballs.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the SPNT Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for SPNT.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (SPNT)

© 2026 Stock Market Info — SiriusPoint Ltd. (SPNT) Financial Profile